Opaleye Management Inc. - Sep 19, 2023 Form 4 Insider Report for HARROW HEALTH, INC. (HROW)

Role
10%+ Owner
Signature
Opaleye Management Inc., By: /s/ James Silverman, President
Stock symbol
HROW
Transactions as of
Sep 19, 2023
Transactions value $
$292,076
Form type
4
Date filed
9/20/2023, 06:39 PM
Previous filing
Apr 20, 2023
Next filing
Nov 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HROW Common Stock, par value $0.001 per share Purchase $205K +14K +0.39% $14.65 3.61M Sep 19, 2023 By Opaleye, L.P. F1, F2
transaction HROW Common Stock, par value $0.001 per share Purchase $86.7K +5.98K +0.17% $14.49 3.62M Sep 20, 2023 By Opaleye, L.P. F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.
F2 The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume-weighted average purchase price of $14.6512. The range of purchase prices per share on the transaction date was $14.59 to $14.73. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
F3 The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume-weighted average purchase price of $14.4928. The range of purchase prices per share on the transaction date was $14.22 to $14.67. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.